MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Genotype-Phenotype Relations in Neurodegeneration with Brain Iron Accumulation (NBIA) Genes: MDSGene Systematic Review

    N. Reyes, R. Patel, J. Rodriguez-Antiguedad, R. Ramalingam, M. Hamed, A. Duarte, E. Fernandez-Toledo, C. Sun, S. Fereshtehnejad, Y. Mahjoub, M. Emamikhah, S. Camargos, J. Trinh, K. Lohmann, C. Klein, C. Marras, D. Olszewska (Brooklyn, USA)

    Objective: To provide a comprehensive review of individual-level data and genotype-phenotype relationships for genes implicated in neurodegeneration with brain iron accumulation (NBIA) disorders. Background: The…
  • 2025 International Congress

    Examining the Impact of a Single Session of Myofascial Release via Dry Needling on Step Length in Individuals with Parkinson’s Disease

    A. Tahara, A. Gastaldi, A. Chinaglia, V. Tumas, P. Santiago (Ribeirão Preto, Brazil)

    Objective: This study aims to elucidate the impact of a singular myofascial release session employing Dry Needling (DN) on step length within a complete gait…
  • 2025 International Congress

    Prevalence and Comorbidities of Orthostatic Hypotension in Older Adults: A Two-Year Study

    ANA. Ovchynnykova, Y. Trufanov (Kyiv, Ukraine)

    Objective: To determine the prevalence of OH and its associations with autonomic dysfunction, falls, and mortality. Background: Orthostatic hypotension (OH) is a common problem that…
  • 2025 International Congress

    The Role of Mitochondrial DNA Haplogroups in determining the Age of Onset in Indian SCA2 Patients.

    A. Sonakar, C. Sharma, S. Reza, S. Pandey, M. Srivastava, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: To investigate the contribution of mitochondrial DNA (mtDNA) haplogroups to the age at onset (AO) of Spinocerebellar Ataxia type 2 (SCA2) in Indian patients,…
  • 2025 International Congress

    Spinocerebellar Ataxia Type 17 First Reported Case in Northern Mexico

    S. Murillo Quintana, D. Sánchez Galván, J. Mejía Chávez, S. Flores Casas, L. Hernández Salomón (Torreón, Coahuila, Mexico)

    Objective: To report the first documented case of spinocerebellar ataxia type 17 (SCA17) in northern Mexico. Background: SCA17 is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Brain Structural Impairment in Spinocerebellar Ataxia Type 6: Not Restricted to the Cerebellum

    B. Massuyama, T. Rezende, M. Junior, O. Barsottini, J. Pedroso (Campinas, Brazil)

    Objective: To characterize the structural brain signature in SCA6 patients. Background: Spinocerebellar ataxias (SCA) refer to a group of autosomal dominant ataxic disorders that result…
  • 2025 International Congress

    The FGF14-SCA27B GAA•TTC Repeat Shows Marked Somatic Expansion in the Cerebellum

    D. Pellerin, JL. Méreaux, S. Boluda, MC. Danzi, MJ. Dicaire, CS. Davoine, P. Iruzubieta, B. Hayward, D. Genis, G. Spurdens, JM. Hammond, BJ. Gerhart, M. Renaud, C. Bonnet, JS. Napierala, IW. Deveson, M. Napierala, K. Usdin, A. Brice, LM. Porcel, D. Seilhean, SL. Zuchner, H. Houlden, A. Durr, B. Brais (London, United Kingdom)

    Objective: To characterize somatic instability and molecular mechanisms of the FGF14 GAA•TTC repeat across serial blood samples, fibroblasts, induced pluripotent stem cells (iPSCs), and post-mortem brains. Background: Spinocerebellar…
  • 2025 International Congress

    Correlations of plasma glial fibrillary acidic protein levels with glymphatic system impairment in Huntington’s disease

    JH. Yin, LY. Lu, Q. Yang, Y. Huang (Beijing, China)

    Objective: To investigate whether plasma glial fibrillary acidic protein (GFAP) levels are related to glymphatic system function in Huntington's disease (HD). Background: Plasma GFAP levels has…
  • 2025 International Congress

    Outcomes of invasive stereotactic thalamotomy using dentatorubrothalamic tractography targeting for patients with drug refractory tremor

    V. Bayarchyk, A. Buniak, A. Mikitchuk (Minsk, Belarus)

    Objective: The purpose of this study was to determine whether tremor reduces in patients after stereotactic thalamotomy using tractography targeting the dentatorubrothalamic (DRT) tract. Background:…
  • 2025 International Congress

    Efficacy and Safety of Dual-Target Transcranial Magnetic Stimulation in Essential Tremor: A Phase 2 Randomized, Controlled, Patient-Assessor blinded Trial

    J. Xu, N. Cao, Y. Qu, S. Shang, X. Bai, X. Liu, X. Liu, X. Wang, F. Hu, Q. Qu, M. Zhang, H. Cao (Xi’an, China)

    Objective: To investigate the efficacy and safety of transcranial magnetic stimulation (TMS) by combined cortical and cerebellar as dual-target in the treatment of essential tremor…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley